Literature DB >> 23983533

Nutritional and Physicochemical Characteristics of the Antidementia Acetylcholinesterase-Inhibiting Methanol Extracts from Umbilicaria esculenta.

Ji-Su Lee1, Gyung-Hun Min, Jong-Soo Lee.   

Abstract

To develop new antidementia nutraceuticals, a potent acetylcholinesterase (AChE)-inhibiting extract was screened from various extracts of nutritional mushrooms and lichens nutritional and its physicochemical properties were investigated. Among the several extracts tested, methanol extracts of Umbilicaria esculenta fruiting body showed the highest AChE inhibitory activity of 22.4%. U. esculenta AChE inhibitor was maximally extracted when fruiting bodies were treated with 80% methanol at 40℃ for 18 h. The methanol extracts contained 18.9% crude lipid, 18.8% crude protein, and 11.6% total sugar. In addition, they contained 444 mg/g glutamic acid, 44 mg/g histidine, and 41 mg/g aspartic acid. The methanol extracts were soluble in a solution of methanol and 20% dimethylsulfoxide, insoluble in n-hexane, chloroform, and water, and were stable at 20~60℃ and pH 1.0~5.0 for 1 h.

Entities:  

Keywords:  Acetylcholinesterase inhibitor; Antidementia; Umbilicaria esculenta

Year:  2009        PMID: 23983533      PMCID: PMC3749388          DOI: 10.4489/MYCO.2009.37.3.203

Source DB:  PubMed          Journal:  Mycobiology        ISSN: 1229-8093            Impact factor:   1.858


Alzheimer's disease is characterized by acetylcholine depletion, amyloid β protein aggregation, and neurofibrillary tangle (Duyckaerts et al., 1999). The neurotransmitter acetylcholine has important recognition functions such as memory (Richter et al., 1980), and it is synthesized in certain neurons by the enzyme choline acetyltransferase from choline and acetyl-CoA. Acetylcholinesterase (AChE) [EC 3.1.1.7] is an enzyme that hydrolyses acetylcholine into choline and acetate. Therefore, it promotes dementia by loss of neurotransmitter in the brain. Many AChE inhibitors have been developed from natural products and ultimately commercialized. However, commercial AChE inhibitors often have negative effects that include toxicity (including to the liver) and vomiting. Therefore, their use in the treatment of dementia is limited (Dubios and Albert, 2004; Muramoto et al., 1979). Recently, lichen have attracted attention because they contain compounds that can be used as medicinal agents or as neutraceuticals in functional foods. Umbilicaria esculenta is a lichen living symbiotically with ascomycetes and green algae or cyanobacteria (Hawksworth, 1988). It is generally found at high altitude on mountain rocks in East Asia. U. esculenta has been used in traditional preventatives and remedies for bloody vomit and diarrhea, skin disease, epilepsy, and yellow jaundice (Jang et al., 2003). Reported physiological functions of U. esculenta have included β-glucan-mediated anti-cancer effect, lecanoric acid- and vulpinic acid-mediated anti-inflammatory effects and histidine-decarboxylase inhibition, fibrinolytic effect, skin anti-aging effect, parietin- and emodin-mediated inhibition of Gram-positive bacteria, and antihyperglycemic effect (Kim et al., 1995; Lee and Kim, 1999; Choi et al., 2000; Jang et al., 2003; Kim and Lee, 2006). U. esculenta also produces plant growth inhibitors such as evernic acid, usnic acid, atranorin, vulpinic acid, and cell division repressors including protolichesterinic acid and nephrosterinic acid (Hawksworth et al., 1984). However, few studies have addressed the anti-dementia potential of U. esculenta AChE inhibitors. To develop new anti-dementia agents from mushrooms and lichens, screening of potent anti-dementia AChE-inhibiting extracts from lichen and optimal extraction conditions of the AChE inhibiting-extract were investigated. Furthermore, the nutritional and physicochemical properties of AChE-inhibiting methanol extracts were also determined.

Materials and Methods

Mushrooms and chemicals

Mushrooms were obtained from the National Institute of Agricultural Science and Technology in Suwon, Korea. Lichens were obtained from the Korea Lichen Research Institute of Suncheon National University in Suncheon, Korea. Unless otherwise specified, all chemicals and solvents were of analytical grade. AChE (recombinant human AChE; rAChE), acetylthiocholine chloride, and 5,5-dithiobis (2-nitrobenzoic acid) (DTNB) were purchased from the Sigma-Aldrich (St. Louis, MO, USA). The VERSAmax microplate reader (Molecular Devices, Sunnyvale, CA, USA) was used in AChE activity measurements.

Extraction of mushrooms and lichen

Mushrooms and lichen powders were separately added to water and methanol (1 : 50, v/v) and shaken for 24 h at 50℃ and 40℃, respectively. Each extract was filtered through a Whatman 0.45 µm membrane filter and lyophilized.

Assay of AChE inhibitory activity

AChE inhibitory activity was measured spectrophotometrically as previously described (Ellman et al., 1961). A mixture of 110 µl assay buffer (0.1M sodium phosphate, pH 7.3), 30 µl AChE (0.8 U/ml), 30 µl substrate (acetylthiocholine chloride), 20 µl of DTNB, and 10 µl sample dissolved in the assay buffer was incubated for 60 min at 37℃. The reaction product, 5-thio-2-nitrobenzoate, which was produced enzymatically, was measured at 415 nm. The inhibition (%) was calculated using the equation: inhibition (%) = [1 - {(S - S0) ÷ (C - C0)}] × 100% where C is the absorbance of a control (enzyme, assay buffer, DTNB, and substrate) after 60 min of incubation, C0 is the absorbance of a control at time zero, S is the absorbance of the tested samples (enzyme, sample solution, DTNB, and substrate) after 60 min of incubation, and S0 is the absorbance of the tested samples at time zero. All data represent the mean of duplicate experiments. To check the quenching effect of the samples, we added the sample solution to reaction mixture C and investigated any reduction in the absorbance of the sample. The IC50 value is defined as the concentration of the AChE inhibitor that is required to inhibit 50% of the AChE activity.

Characterization of AChE-inhibiting methanol extracts from U. esculenta

Protein and total sugar content of the AChE-inhibiting methanol extracts from U. esculenta were determined by the Lowry and phenol-sulfuric acid methods, respectively (Kim et al., 2008). Crude lipid content was determined by the Soxhlet extraction method and amino acid content was determined using high-pressure liquid chromatography (Kim et al., 2008).

Results and Discussion

Screening of AChE-inhibiting extracts from mushroom and lichen

AChE inhibitory activities of water and methanol extracts from mushrooms and lichens are summarized in Table 1. Methanol extracts of U. esculenta showed the highest AChE inhibitory activity of 22.4%, with activities of the other extracts being lower or undetectable. Even though the AChE inhibitory activity of methanol extracts from U. esculenta was lower than that of Sorghum bicolor (63.4%) (Song, 2008), this is the first report concerning the presence of an AChE inhibitor from U. esculenta.
Table 1

AChE inhibitory activities of various extracts from secondary-screened mushrooms and lichens

a)Extract concentration = 1 mg/ml, b)N.D: not detected, c)Values show mean ± SE from three experiments performed in triplicate

Optimal conditions for AChE inhibitor extraction

Effects of methanol concentration, extraction temperature, and time on the AChE inhibitory activity of the methanol extracts were determined (Figs. 1 and 2). The AChE inhibitor was maximally extracted when U. esculenta was treated by 80% methanol at 40℃ for 18 h.
Fig. 1

Effects of methanol concentration on extraction of AChE inhibitor from U. esculenta.

Fig. 2

Effects of extraction time and temperature on extraction of AChE inhibitor from U. esculenta.

Nutritional characteristics of AChE-inhibiting methanol extracts

The AChE-inhibiting methanol extracts from U. esculenta contained 18.8% of crude protein, 11.6% of total sugar, and 18.9% crude lipid per gram. Amino acid content of the methanol extracts was determined (Table 2), and included aspartic acid (41 mg/g), histidine (44 mg/g), alanine (34 mg/g), and, very notably, glutamic acid (444 mg/g). These amino acid contents were 4.0~30 times higher than those of the corresponding contents of aspartic acid (10.66 mg/g solid), histidine (7.95 mg/g solid), alanine (10.27 mg/g solid), and glutamic acid (15.84 mg/g solid) in Lentinus edodes (Korean Food Components Index, 2006). Furthermore, besides the AChE inhibitory activity of the methanol extracts, the high glutamic acid content evident in U. esculenta extracts is probably related to the function of glutamic acid in the brain as an energy source for neurotransmitter stimulation and excitation.
Table 2

Amino acid contents of the methanol extracts from U. esculenta

a)Unit = mg/g solid

Physicochemical properties of AChE-inhibiting methanol extracts

The methanol extracts from U. esculenta were soluble in methanol and 20% dimethyl sulfoxide (DMSO), and were insoluble in n-hexane, chloroform, ethyl acetate, and water (Table 3). Thermal and pH stability of the methanol extracts were investigated (Figs. 3 and 4). The methanol extracts were stable in the range of 20~60℃ and pH 1.0~5.0 for 1 h.
Table 3

Physicochemical properties of the AChE-inhibiting methanol extracts from U. esculenta

Fig. 3

Thermal stability of the methanol extracts from U. esculenta.

Fig. 4

pH stability of the methanol extracts from U. esculenta.

In conclusion, we obtained a highly valuable U. esculenta extracts which were contained various nutritional compounds and antidementia AChE inhibitor. We are confident that the methanol extracts of U. esculenta from this study will become a good nutraceutical for preparation of functional foods. Further studies should purify and characterize the AChE inhibitor from U. esculenta.
  6 in total

1.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

Review 2.  [Alzheimer's disease: lesions and their progression].

Authors:  C Duyckaerts; M A Colle; B Delatour; J J Hauw
Journal:  Rev Neurol (Paris)       Date:  1999       Impact factor: 2.607

3.  Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease.

Authors:  J A Richter; E K Perry; B E Tomlinson
Journal:  Life Sci       Date:  1980-05-19       Impact factor: 5.037

4.  Effect of physostigmine on constructional and memory tasks in Alzheimer's disease.

Authors:  O Muramoto; M Sugishita; H Sugita; Y Toyokura
Journal:  Arch Neurol       Date:  1979-08

5.  Antithrombotic activity of methanolic extract of Umbilicaria esculenta.

Authors:  Moo-Sung Kim; Kyung-Ae Lee
Journal:  J Ethnopharmacol       Date:  2005-12-27       Impact factor: 4.360

6.  Amnestic MCI or prodromal Alzheimer's disease?

Authors:  Bruno Dubois; Martin L Albert
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

  6 in total
  4 in total

1.  Phytochemical Characterization and Pharmacological Properties of Lichen Extracts from Cetrarioid Clade by Multivariate Analysis and Molecular Docking.

Authors:  Isabel Ureña-Vacas; Elena González-Burgos; Simona De Vita; Padreep K Divakar; Giuseppe Bifulco; M Pilar Gómez-Serranillos
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-02       Impact factor: 2.650

2.  Isolation, Identification and Characterization of a Antidementia Acetylcholinesterase Inhibitor-Producing Yarrowia lipolytica S-3.

Authors:  Min-Gu Kang; Min-Ho Yoon; Young-Jun Choi; Jong-Soo Lee
Journal:  Mycobiology       Date:  2012-03-31       Impact factor: 1.858

3.  Optimal Extraction Conditions of Anti-obesity Lipase Inhibitor from Phellinus linteus and Nutritional Characteristics of the Extracts.

Authors:  Jong-Kug Lee; Jung-Hwa Song; Jong-Soo Lee
Journal:  Mycobiology       Date:  2010-03-31       Impact factor: 1.858

4.  Phytochemical Composition, Antioxidant Activity, α-Glucosidase and Acetylcholinesterase Inhibitory Activity of Quinoa Extract and Its Fractions.

Authors:  Xi Chen; Xuemei He; Jian Sun; Zhenxing Wang
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.